Emcure Pharmaceuticals Limited (BOM:544210)
India flag India · Delayed Price · Currency is INR
1,384.80
-14.00 (-1.00%)
At close: Aug 8, 2025

Emcure Pharmaceuticals Company Description

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular.

It provides its products under Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym brand names.

Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.

Emcure Pharmaceuticals Limited
Country India
Founded 1981
Industry Pharmaceutical Preparations
Employees 6,731
CEO Satish Mehta

Contact Details

Address:
Plot No. P-1 and P-2
Pune, Maharashtra 411057
India
Phone 91 20 3507 0033
Website emcure.com

Stock Details

Ticker Symbol 544210
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2834

Key Executives

Name Position
Satish Mehta Chief Executive Officer
Tajuddin Shaikh Chief Financial Officer
Samit Mehta Chief Operating Officer